# 7 Days vs. 14 Days of Vonoprazan-based Triple Therapy for H. Pylori Eradication

> **NCT06576882** · PHASE3 · COMPLETED · sponsor: **Alexandria University** · enrollment: 326 (actual)

## Conditions studied

- Helicobacter Pylori Infection
- Gastritis
- Vonoprazan
- Adolescents

## Interventions

- **DRUG:** Vonoprazan
- **DRUG:** Amoxicillin
- **DRUG:** Clarithromycin

## Key facts

- **NCT ID:** NCT06576882
- **Lead sponsor:** Alexandria University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-06-30
- **Primary completion:** 2024-11-01
- **Final completion:** 2024-12-01
- **Target enrollment:** 326 (ACTUAL)
- **Last updated:** 2025-02-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06576882

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06576882, "7 Days vs. 14 Days of Vonoprazan-based Triple Therapy for H. Pylori Eradication". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT06576882. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*